Intrinsic value of life sciences company Malin dips again
Company plans to return €45m to shareholders after 175% gain on sale of CG Technology stake
Company plans to return €45m to shareholders after 175% gain on sale of CG Technology stake
Mark Graham and Ellie O’Byrne share their favourite cycles in Ireland for all levels of ability from paved paths to off road adventures perfect for making the most out of the long weekend
Former Glen Dimplex chief executive has added to his stakes in Datalex and Malin
Sophie Power endured sleep deprivation, hallucinations, injury and the Irish ‘summer’ to become the fastest woman to run the length of Ireland
Life sciences investment company returned €140m to investors earlier this year by way of share buyback
Fiona Dunlevy to be appointed executive director at Dublin-based life sciences investment company, with Liam Daniel as executive chairman
Plan was initially announced in December after sale of Immunocore stake
Move is part of latest proposal to return cash to shareholders
Founder shareholders had been seeking to convert shares into direct stock
Irish-listed healthcare group defied Covid-19 pandemic to deliver a 31% surge in profits
Event at Mansion House on April 21 will include Business Person of the Year prize
Apple soared and Zoom slumped in a year that saw markets surge to record levels
Uniphar’s gross profit surges 31% in the first half of the year
Plan was to return €80m to shareholders through programme
Plans were announced last month following sale of Altan stake
Pentwater Capital’s overall interest up from 27.6 per cent so far this year to 28.6 per cent
Move comes as company goes about returning most of €118m cash to stockholders
Altan, which employs 250 people, manufactures and markets injectable medications
Dublin-headquartered company helps patients better adhere to medication schedules
Life sciences company had a 65% stake in Altan, which it acquired for €34.5m in 2015
Life sciences investor said sale would deliver gross upfront proceeds of $113m
Cantillon: Malin prevented from selling stock for at least 180 days under lock-up agreement
The UK biotech company says proceeds from the IPO will be used to advance its lead product
Irish investor has 7.4% stake in UK biotech company developing eye cancer therapy
Market Beat: Life sciences company is finally delivering, six years after IPO
Irish life sciences company holds 10% stake in immunotherapy firm
Life sciences investment firm has said its revenue-generating assets performing well
Business Today: the best news, analysis and comment from The Irish Times business desk
Poseida Therapeutics is expected to begin trading on the Nasdaq on Friday
Shares in Dublin-based life sciences group have rallied by more than 250% since March
Poseida is one of four priority assets in which the life sciences company has stakes
Germ-zapping robot firm backed by Malin sees spike in demand amid virus outbreak
New targets set for inclusion of women on leadership teams and in private companies
Healthcare investor Malin receives €17m for its stake following sale of business to Elsevier
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices